StockSelector.com
  Research, Select, & Monitor Saturday, August 18, 2018 4:34:47 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Protalix BioTherapeutics Inc$0.47   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Protalix BioTherapeutics Inc has an overall rank of 6558 out of 7022 stocks based on 3 positive rankings and 8 negative rankings.

Positive Rankings
PEGValue
Protalix BioTherapeutics Inc has a PEG Value of $3,306.00. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 695,900.00% in the next year. Among companies with a PEG Value above the current stock price, Protalix BioTherapeutics Inc is ranked 1.
SSValue
The StockSelector Value for Protalix BioTherapeutics Inc is $3.83. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Protalix BioTherapeutics Inc is ranked 148.
90 Day Gain
Protalix BioTherapeutics Inc rank is 1855
Negative Rankings
Negative ROA
Protalix BioTherapeutics Inc rank is 214
Negative Net Margin
Protalix BioTherapeutics Inc rank is 320
Negative Revenue Growth
Protalix BioTherapeutics Inc rank is 354
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Protalix BioTherapeutics Inc is ranked 629.
Down EPS Surprise
Protalix BioTherapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Cash Growth
Protalix BioTherapeutics Inc rank is 1246
10 Day Loss
Protalix BioTherapeutics Inc rank is 1313
Price-to-Sales
Protalix BioTherapeutics Inc rank is 1376







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.